EPN-26 ONCOLOGY DRUG SCREEN IDENTIFIES EPENDYMOMA-SELECTIVE POTENCY OF 5-FU ANALOGS AND mTOR INHIBITORS

Ítems similars

• EPN-28 GM-CSF IS CRITICAL FOR TRASTUZUMAB EFFICACY IN PEDIATRIC EPENDYMOMA
  per: Donson, Andrew, et al.
  Publicat: (2016)
• EPN-23 CHARACTERIZATION OF TWO NOVEL 1q+ EPENDYMOMA CELL LINES
  per: Amani, Vladimir, et al.
  Publicat: (2016)
• Identification of FDA-approved oncology drugs with selective potency in high-risk childhood ependymoma.
  per: Donson, Andrew M., et al.
  Publicat: (2018)
• EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
  per: Griesinger, Andrea, et al.
  Publicat: (2020)
• EPEN-14. SUBGROUP-SPECIFIC THERAPY OPTIONS FOR CHILDHOOD SUPRATENTORIAL EPENDYMOMA
  per: Amani, Vladimir, et al.
  Publicat: (2018)